Skip to main content
. 2018 Dec 17;2018:3810108. doi: 10.1155/2018/3810108

Figure 3.

Figure 3

Sensitivity to MLN2283/ixazomib and LBH589/panobinostat combination treatment is dependent on the expression of GOF TP53. Sensitivity to MLN2238/ixazomib alone (a) or in combination with LBH589/panobinostat (b) was examined in parental Hec50 cells or Hec50 cells expressing the R175H GOF mutant. ∗∗∗P < 0.001 by two-way ANOVA with Sidak's multiple comparison test.